Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most often read
Journal Information

Most often read

13464
Position statement on the use of albumin in liver cirrhosis
Graciela Castro-Narro, Carlos Moctezuma-Velázquez, Rene Male-Velázquez, Rafael Trejo-Estrada, Francisco Javier Bosques, Rosalba Moreno-Alcántar, Heriberto Rodríguez-Hernández, Aleida Bautista-Santos, ... Aldo Torre
Ann Hepatol. 2022;27:100708
13464
Open access
12465
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?
Diego García-Compeán, Alan Rafael Jiménez-Rodríguez
Ann Hepatol. 2022;27:100765
12465
Full text access
10979
Acid-base abnormalities and liver dysfunction
Periklis Katopodis, Efthymios M. Pappas, Konstantinos P. Katopodis
Ann Hepatol. 2022;27:100675
10979
Open access
8180
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
8180
Open access
6406
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
6406
Open access
5627
Current approaches to hepatic encephalopathy
Paulina Vidal-Cevallos, Norberto C. Chávez-Tapia, Misael Uribe
Ann Hepatol. 2022;27:100757
5627
Full text access
5493
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
Pegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
5493
Open access
5372
Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis
Babu Pappu Mohan, Sentia Iriana, Shahab Rasool Khan, Pradeep Yarra, Suresh Ponnada, Juan Fernando Gallegos-Orozco
Ann Hepatol. 2022;27:100741
5372
Full text access
4948
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
4948
Open access
4219
Management of COVID-19 patients with chronic liver diseases and liver transplants
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
Ann Hepatol. 2022;27:100653
4219
Open access
3886
CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTS
A.B. Moreno-Cobos, J.L. Pérez-Hernández, B.A. Enríquez-Constantino, M.Y Carmona-Castillo, E.J. Medina-Ávalos, C.L. Dorantes-Nava, M.F. Higuera-De la Tijera
Ann Hepatol. 2022;27 Supl 2:100589.12
3886
Open access
3305
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Ann Hepatol. 2022;27:100702
3305
Open access
3280
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
Somayeh Shokri, Shahab Mahmoudvand
Ann Hepatol. 2022;27:100704
3280
Open access
3277
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Ann Hepatol. 2022;27:100699
3277
Open access
3169
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil
Marlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, ... Daniel F. Mazo
Ann Hepatol. 2022;27:100543
3169
Open access
3109
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B
Tania Queiroz Reuter, Michele Gomes-Gouvea, Samira Chuffi, Ulisses Horst Duque, José Americo Carvalho, Waltesia Perini, Marcello Moro Queiroz, Ingrid Marques Segal, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100574
3109
Open access
3041
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico
Luis E. Gomez-Quiroz, Sonia Roman
Ann Hepatol. 2022;27 Supl 1:100649
3041
Open access
2605
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts
Qiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, ... Wuhua Guo
Ann Hepatol. 2022;27:100725
2605
Open access
2581
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Wolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, ... Christian Labenz
Ann Hepatol. 2022;27:100719
2581
Open access
2580
The impact of COVID-19 on the cascade of care of HCV in the US and China
Yee Hui Yeo, Xu Gao, Jian Wang, Qingyu Li, Xingyang Su, Yu Geng, Rui Huang, Chao Wu, ... Walid S. Ayoub
Ann Hepatol. 2022;27:100685
2580
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos